msgarra

Transcatheter heterotopic valve implantation with the TricValve system: focus on preoperative assessment and patient selection.

Nontreated severe symptomatic tricuspid valve regurgitation is associated with significant morbidity and mortality. When a surgical correction is not feasible due to high operative risk, transcatheter treatment of the tricuspid valve has been suggested as an interesting valuable option.

Transcatheter heterotopic valve implantation with the TricValve system: focus on preoperative assessment and patient selection. Read More »

Transcatheter heterotopic valve implantation with the TricValve system: focus on preoperative evaluation and patient selection.

Untreated severe symptomatic tricuspid valve regurgitation is associated with significant morbidity and mortality. When surgical correction is not feasible due to high operative risk, transcatheter tricuspid valve treatment has been suggested as an attractive value option.

Transcatheter heterotopic valve implantation with the TricValve system: focus on preoperative evaluation and patient selection. Read More »

Scroll to Top